Sign in
Taking peopleNo phase

How patients' expectations relate to lingering symptoms after early Lyme disease

Studies whether expectations before antibiotic treatment relate to later symptoms in adults with erythema migrans.

Key facts

Who runs it
University Medical Centre Ljubljana
Where
Slovenia1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Patient's Pretreatment Expectations About Post-Lyme Symptoms
Status
Recruiting
People taking part
200 people, planned
Started
1 Jun 2018
Expected to end
1 Dec 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Antibiotics (preferentially oral doxycycline 100 mg bid)
Record updated
29 April 2026

Who can take part

The trial is looking for adults with early Lyme disease that shows as erythema migrans, a spreading red skin rash after a tick bite. It also includes control people of similar age who never had Lyme disease.

Age
18 Years and older
Sex
All sexes can join
Disease stage
Early Lyme disease shown as erythema migrans (red skin rash)
Earlier treatment
People who took an antibiotic that works against Borrelia within 10 days cannot join
Main reasons for not taking part
  • Pregnancy
  • Breastfeeding
  • Weakened immune system
  • Antibiotic against Borrelia taken within 10 days
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • erythema migrans

Who cannot take part

  • pregnancy or lactation
  • immunocompromised
  • taking antibiotic with antiborrelial activity within 10 days

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Erythema migrans

This trial is currently available in Slovenia.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The investigators will focus on pretreatment expectations of patients with early Lyme disease manifested as erythema migrans with the aim of assessing the association between pretreatment expectations quantified with a questionnaire and treatment outcome quantified with the presence of post-Lyme symptoms. Furthermore, the investigators will compare the prevalence of nonspecific symptoms among patients and among age-matched controls without a history of Lyme borreliosis.

The 2 groups in the trial

  • patients with erythema migransExisting treatment, for comparison

    Patients will be treated with antibiotics for Lyme disease.

    Treatment: Antibiotics (preferentially oral doxycycline 100 mg bid)

  • controlsNo study treatment, for comparison

    Control subjects will not be given antibiotics.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Patient's Pretreatment Expectations on Treatment Outcome of Early Lyme Borreliosis
Plain-language title
How patients' expectations relate to lingering symptoms after early Lyme diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT03462329, who can take part
Record updated
29 April 2026